Post-approval studies (Phase 4)UnknownNCT05021276
What this trial is testing
Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD
Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 50